Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;29(15):2400178.
doi: 10.2807/1560-7917.ES.2024.29.15.2400178.

Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024

Affiliations

Excess mortality in Europe coincides with peaks of COVID-19, influenza and respiratory syncytial virus (RSV), November 2023 to February 2024

Sarah K Nørgaard et al. Euro Surveill. 2024 Apr.

Abstract

Since the end of November 2023, the European Mortality Monitoring Network (EuroMOMO) has observed excess mortality in Europe. During weeks 48 2023-6 2024, preliminary results show a substantially increased rate of 95.3 (95% CI: 91.7-98.9) excess all-cause deaths per 100,000 person-years for all ages. This excess mortality is seen in adults aged 45 years and older, and coincides with widespread presence of COVID-19, influenza and respiratory syncytial virus (RSV) observed in many European countries during the 2023/24 winter season.

Keywords: EuroMOMO; Excess mortality; respiratory infections; surveillance.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

Figures

Figure 1
Figure 1
EuroMOMO pooled estimates and observed numbers of all-cause mortality per 100,000 person-years for (A) all ages and (B–G) by age group, 25 participating countries or subnational areasa, week 41 2023–week 12 2024
Figure 2
Figure 2
Estimated z-scores of excess all-cause mortalities by ISO week, 25 participating countries or subnational areasa, week 41 2023–week 12 2024
Figure 3
Figure 3
Pathogen-specific test positivity of SARS-CoV-2, influenza and RSV for all ages based on (A) primary care sentinel data and (B) non-sentinel data submitted to TESSy, 25 countriesa, week 41 2023–week 12 2024

Similar articles

Cited by

References

    1. Nielsen J, Vestergaard LS, Richter L, Schmid D, Bustos N, Asikainen T, et al. European all-cause excess and influenza-attributable mortality in the 2017/18 season: should the burden of influenza B be reconsidered? Clin Microbiol Infect. 2019;25(10):1266-76. 10.1016/j.cmi.2019.02.011 - DOI - PubMed
    1. Vestergaard LS, Nielsen J, Krause TG, Espenhain L, Tersago K, Bustos Sierra N, et al. Excess all-cause and influenza-attributable mortality in Europe, December 2016 to February 2017. Euro Surveill. 2017;22(14):30506. 10.2807/1560-7917.ES.2017.22.14.30506 - DOI - PMC - PubMed
    1. Vestergaard LS, Nielsen J, Richter L, Schmid D, Bustos N, Braeye T, et al. Excess all-cause mortality during the COVID-19 pandemic in Europe - preliminary pooled estimates from the EuroMOMO network, March to April 2020. Euro Surveill. 2020;25(26):2001214. 10.2807/1560-7917.ES.2020.25.26.2001214 - DOI - PMC - PubMed
    1. Nørgaard SK, Vestergaard LS, Nielsen J, Richter L, Schmid D, Bustos N, et al. Real-time monitoring shows substantial excess all-cause mortality during second wave of COVID-19 in Europe, October to December 2020. Euro Surveill. 2021;26(2):2002023. 10.2807/1560-7917.ES.2021.26.1.2002023 - DOI - PMC - PubMed
    1. Sinnathamby MA, Whitaker H, Coughlan L, Lopez Bernal J, Ramsay M, Andrews N. All-cause excess mortality observed by age group and regions in the first wave of the COVID-19 pandemic in England. Euro Surveill. 2020;25(28):2001239. 10.2807/1560-7917.ES.2020.25.28.2001239 - DOI - PMC - PubMed